We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter's New Solutions Demonstrated at 2013 AACC Annual Meeting

By LabMedica International staff writers
Posted on 01 Aug 2013
Print article
Beckman Coulter (Brea, CA, USA) demonstrated its dedication to advancing and optimizing the lab at the 2013 American Association of Clinical Chemistry (AACC) and Clinical Lab Expo in Houston (TX, USA) from July 30–August 1, 2013.

The Beckman Coulter exhibition booth showcased the company’s latest products in total lab automation, scalable solutions, and small footprint systems, including the new Power Express automation solution which streamlines lab workflow and increases flexibility to ultimately decrease turnaround time. The Power Link, also demonstrated, offers labs the ability to combine an AU680 chemistry analyzer with a DxI immunoassay analyzer to form an entry level automated workcell.

Moreover, the latest addition of the IRIS Diagnostics (Chatsworth, CA, USA) urinalysis portfolio and presentations on the company’s newest troponin I assay, AccuTnI+3 on the Access 2 immunoassay system was demonstrated.

Attendees were given opportunities to view Beckman Coulter's newest cellular analysis systems, high-throughput chemistry analyzers, and clinical information solutions in a unique booth design that exhibits the company’s lab automation for the core, reference, and community hospital lab.

Visitors to Beckman Coulter’s booth have the opportunity to learn from industry experts how the company’s latest diagnostic innovations advance and optimize patient care and hear examples of how Beckman Coulter moves the lab forward by increasing efficiency, productivity, and uptime.

Related Links:
Beckman Coulter
Iris Diagnostics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.